Oral Prostacyclin Therapy for Pulmonary Arterial Hypertension Another Step Forward

被引：5
|
作者：
Waxman, Aaron B. [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
来源：
CIRCULATION | 2013年 / 127卷 / 05期
关键词：
Editorials; epoprostenol; hypertension; pulmonary; pulmonary artery; pulmonary circulation; DOUBLE-BLIND; TREPROSTINIL; EPOPROSTENOL; SURVIVAL; EFFICACY; MULTICENTER; SAFETY; NEED;
D O I：
10.1161/CIRCULATIONAHA.112.000675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：563 / 565
页数：3
相关论文
共 50 条
  • [1] Prostacyclin Therapy for Pulmonary Arterial Hypertension
    Ruan, Cheng-Huai
    Dixon, Richard A. F.
    Willerson, James T.
    Ruan, Ke-He
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (04) : 391 - 399
  • [2] Pulmonary Arterial Hypertension: New Insights Into the Optimal Role of Current and Emerging Prostacyclin Therapies
    Waxman, Aaron B.
    Zamanian, Rohani T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (05) : 1A - 16A
  • [3] The prostacyclin pathway in pulmonary arterial hypertension: a clinical review
    Del Pozo, R.
    Hernandez Gonzalez, I.
    Escribano-Subias, P.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (06) : 491 - 503
  • [4] Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
    Safdar, Zeenat
    RESPIRATORY MEDICINE, 2011, 105 (06) : 818 - 827
  • [5] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Frost, Adaani E.
    Barst, Robyn J.
    Hoeper, Marius M.
    Chang, Hyuk-Jae
    Frantz, Robert P.
    Fukumoto, Yoshihiro
    Galie, Nazzareno
    Hassoun, Paul M.
    Klose, Hans
    Matsubara, Hiromi
    Morrell, Nicholas W.
    Peacock, Andrew J.
    Pfeifer, Michael
    Simonneau, Gerald
    Tapson, Victor F.
    Torres, Fernando
    Vizza, Carmine Dario
    Lawrence, David
    Yang, Wei
    Felser, James M.
    Quinn, Deborah A.
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (11) : 1366 - 1375
  • [6] Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series
    Enderby, C. Y.
    Soukup, M.
    Al Omari, M.
    Zeiger, T.
    Burger, C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (05) : 496 - 500
  • [7] Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension
    Walkey, Allan J.
    Fein, Daniel
    Horbowicz, Kevin J.
    Farber, Harrison W.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (04) : 421 - 425
  • [8] Role of Combination Therapy in the Treatment of Pulmonary Arterial Hypertension
    Abraham, Teena
    Wu, Gary
    Vastey, Fabienne
    Rapp, Jonathan
    Saad, Nasser
    Balmir, Eric
    PHARMACOTHERAPY, 2010, 30 (04): : 390 - 404
  • [9] Prostacyclins in Pulmonary Arterial Hypertension: the Need for Earlier Therapy
    Vachiery, Jean-Luc
    ADVANCES IN THERAPY, 2011, 28 (04) : 251 - 269
  • [10] Advances in targeted therapy for pulmonary arterial hypertension in children
    Li, Li
    Zhu, Xinyu
    Chen, Xiaojie
    Gao, Jieyun
    Ding, Chunchun
    Zhang, Min
    Ma, Shixun
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (05) : 2067 - 2076
12345